Home/ Supplements/ Dim/ DIM 400 mg

DIM 400 mg

product on market Capsule SuperSmart Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · grounded in 1 source · methodology

Diindolylmethane is researched for its role in modulating estrogen metabolism and supporting hormonal balance. Current evidence for these effects is generally considered limited to moderate. This ingredient profile maintains a high safety score with no significant concerns noted.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for DIM 400 mg
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
30
Servings
Non-Nutrient/Non-Botanical
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Market median: 200.0mg (3 products) 11 studies (A:1, B:3)

Other Ingredients

Acacia Gum
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Recommended use: Adults. Women - one to two vegetarian capsules a day, men - three to four capsules a day.

Warnings & Precautions

Do not exceed the recommended daily dose. This product is a nutritional supplement and should not replace a varied, balanced diet.

Keep out of children's reach.

As with any nutritional supplement, you should consult a health professional before taking this product if you are pregnant, breastfeeding or have a health problem.

Formulation Notes

Hormonal support

Di-indolylmethane 400 mg per day

Each capsule contains 100 mg di-indolylmethane (DIM).

Additional Information

Precautions: Keeps better when refrigerated.

Store away from direct light, heat and humidity.

Metadata

Product Details

UPC / SKU5 453003 824763
DSLD Entry Date2024-07-25
Product TypeNon-Nutrient/Non-Botanical
FormCapsule
DSLD ID315545
Data Updated2026-04-11
Research

Research Evidence

5
Research Sources
44
Avg Quality
5
Rct
C A randomized, placebo-controlled trial of diindolylmethane for breast cancer biomarker modulation in patients taking tamoxifen
Rct Breast cancer research and treatment 2017 PubMed DOI
C Phase Ib placebo-controlled, tissue biomarker trial of diindolylmethane (BR-DIMNG) in patients with prostate cancer who are undergoing prostatectomy
Rct European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2016 PubMed DOI
C Effectiveness of 3,3'-Diindolylmethane Supplements on Favoring the Benign Estrogen Metabolism Pathway and Decreasing Body Fat in Premenopausal Women
Rct Nutrition and cancer 2023 PubMed DOI
C The effects of light exposure on the cortisol stress response in human males.
Rct Stress (Amsterdam, Netherlands) PubMed DOI
D Pilot study: effect of 3,3'-diindolylmethane supplements on urinary hormone metabolites in postmenopausal women with a history of early-stage breast cancer
Rct Nutrition and cancer 2004 PubMed
View all evidence for Dim →
Compare

Similar Products

View all Dim products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.